Stockscreener 앱 받기
208.45
0.04%
0.09
시간 외 거래:
207.80
-0.65
-0.31%
전일 마감가:
$208.36
열려 있는:
$208.14
하루 거래량:
488.00K
Relative Volume:
0.49
시가총액:
$22.98B
수익:
$10.52B
순이익/손실:
$999.00M
주가수익비율:
24.93
EPS:
8.3628
순현금흐름:
$1.22B
1주 성능:
+0.31%
1개월 성능:
+10.16%
6개월 성능:
+15.73%
1년 성능:
+19.11%
1일 변동 폭
$207.11
$209.76
1주일 범위
$203.89
$213.50
52주 변동 폭
$157.20
$213.50
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
Compare DGX vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
208.45 | 22.97B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Quest Diagnostics (NYSE: DGX) EVP sells shares and disposes stock for taxes - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP sells 526 shares in plan - Stock Titan
Quest Diagnostics (NYSE: DGX) CEO discloses 10,000-share stock sale - Stock Titan
Quest Diagnostics (DGX) SVP sells and withholds shares under plan - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP covers tax obligations with share sale - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP reports tax-withholding stock disposition on Form 4 - Stock Titan
Quest Diagnostics Remains a Dominant Competitor in Independent Labs - Morningstar
Catherine Doherty reports 27,598 DGX share dispositions in Form 144 (NYSE: DGX) - Stock Titan
DGX insider sale notice (DGX) — 526 vested shares; prior 1,111 sold - Stock Titan
Insider sale notice for DGX (DGX): Plewman lists proposed share disposals - Stock Titan
Victory Capital Management Inc. Sells 465,252 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
DGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Quest Diagnostics launches AI tool to analyze lab results By Investing.com - Investing.com Canada
DGX (NYSE: DGX) Form 144 shows proposed sale of 10,000 shares - Stock Titan
Quest Diagnostics Rolls Out Gemini-Powered AI Tool to Explain Lab Results - marketscreener.com
New Quest AI chat uses 5 years of lab data to spot potential health risks - Stock Titan
Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Sustainable Dividend Stock - ChartMill
Quest Diagnostics Incorporated $DGX Position Lowered by IVY Lane Capital Management LLC - MarketBeat
Bahl & Gaynor Inc. Decreases Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
APG Asset Management N.V. Cuts Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Bought by American Century Companies Inc. - MarketBeat
DGX SEC FilingsQuest Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Quest Diagnostics Incorporated $DGX Shares Sold by Vestmark Advisory Solutions Inc. - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Quest Diagnostics (NYSE:DGX) Sets New 1-Year HighWhat's Next? - MarketBeat
Quest Diagnostics stock reaches all-time high at 213.21 USD By Investing.com - Investing.com Canada
Quest Diagnostics appoints Beauvalot to SVP, chief strategy and M&A officer - ROI-NJ
Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement - TipRanks
In Insight Molecular Diagnostics Inc. Enters into A Specimen Collection Agreement with Quest Diagnostics Incorporated - marketscreener.com
Quest Diagnostics Announces Appointment of Benjamin Beauvalot as Senior Vice President, Chief Strategy and M&A Officer - marketscreener.com
After nearly 80 deals, Quest Diagnostics names new M&A chief - Stock Titan
According to a document submitted to the U.S. Securities and Exchange Commission (SEC), Insight Molecular Diagnostics Inc. has reached a service agreement with Quest Diagnostics. - Bitget
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference - Finviz
Quest Diagnostics CFO to outline strategy, market trends at Leerink 2026 event - Stock Titan
Citigroup Inc. Acquires 25,666 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Guardant Health Expands Cancer Testing Platform With MetaSight Deal And Shield Growth - Yahoo Finance
Quest Diagnostics (NYSE:DGX) EVP Sells $293,521.39 in Stock - Defense World
Quest Diagnostics (NYSE:DGX) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Compass Wealth Management LLC Makes New Investment in Quest Diagnostics Incorporated $DGX - Defense World
ANTIPODES PARTNERS Ltd Has $11.76 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (NYSE:DGX) SVP Sells $196,227.14 in Stock - MarketBeat
Insider Selling: Quest Diagnostics (NYSE:DGX) SVP Sells 1,111 Shares of Stock - MarketBeat
Quest Diagnostics (NYSE: DGX) CEO awarded options and RSUs, shares withheld for taxes - Stock Titan
Quest Diagnostics (DGX) EVP logs stock sale, option and RSU awards - Stock Titan
Quest Diagnostics (DGX) SVP logs option, RSU grants and tax share disposals - Stock Titan
Dividend plan boosts Quest Diagnostics (NYSE: DGX) director holdings - Stock Titan
Quest Diagnostics (DGX) director acquires 67 shares through dividend reinvestment - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP gets options, RSUs and tax withholdings - Stock Titan
A diagnostics company moved out. Its former landlord claims it left a mess. - The Business Journals
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.25%
자본화:
|
볼륨(24시간):